Dr. Gagandeep Kaur, MD

Dr. Kaur practices at Adventist Health and Rideout in Marysville, California, part of Adventist Health.

Dr. Kaur's NPI, 1780624130, was assigned on June 7, 2006. Dr. Kaur graduated from Government Medical College Amritsar in 2000. Dr. Kaur holds California license A903940.

Dr. Kaur's primary practice is Adventist Health and Rideout, at 726 4th St, Marysville, CA 95901 in Yuba County. The practice phone is (530) 749-4300.

Dr. Kaur's primary practice is Adventist Health and Rideout in Marysville, California, part of Adventist Health. The medical group on file is Vituity.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Kaur is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kaur is licensed in California.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, bone infection, cardiac arrhythmia, cellulitis, chest trauma and circulation problems among the conditions Dr. Kaur treats.

CMS data shows 1,325 Medicare services from Dr. Kaur across 5 procedure codes in 2024, for 409 Medicare patients. Medicare paid $115,956 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 409 Medicare patients who saw Dr. Kaur in 2024. The largest group is 75 to 84, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 62% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 62, with 50% women.

In 2024, Dr. Kaur wrote 383 Medicare Part D claims for 150 patients. 81% of them were for generic drugs. CMS names the drug for 129 of them, across 8 drugs with 11 or more claims each, at $511 in total drug cost. In 2023, CMS named 155 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Kaur for performance year 2024, reported as part of a group. Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Kaur, published from 2020 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Mesenchymal Stem Cells, Cell Culture Techniques and Cell Differentiation.

CMS Open Payments shows 52 general payments to Dr. Kaur from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $177.

Dr. Kaur graduated from Government Medical College Amritsar in 2000. Dr. Kaur is a member of ACP.

Dr. Kaur is in network with 6 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.